Enhancement of abiraterone acetate oral bioavailability by supersaturated-silica lipid hybrids
-
Published:2020-05
Issue:
Volume:582
Page:119264
-
ISSN:0378-5173
-
Container-title:International Journal of Pharmaceutics
-
language:en
-
Short-container-title:International Journal of Pharmaceutics
Author:
Schultz Hayley B.,
Wignall Anthony D.,
Thomas NickyORCID,
Prestidge Clive A.
Subject
Pharmaceutical Science
Reference61 articles.
1. Open-label, phase I, pharmacokinetic studies of abiraterone acetate in healthy men;Acharya;Cancer Chemother. Pharmacol.,2012
2. A Phase I, open-label, single-dose, mass balance study of 14C-labeled abiraterone acetate in healthy male subjects;Acharya;Xenobiotica,2013
3. Facilitating gastrointestinal solubilisation and enhanced oral absorption of SN38 using a molecularly complexed silica-lipid hybrid delivery system;Bala;Eur. J. Pharm. Biopharm.,2016
4. Evaluation of the pharmacokinetics of abiraterone acetate and abiraterone following single-dose administration of abiraterone acetate to healthy subjects;Bouhajib;Clin. Drug Invest.,2019
5. Food effects on abiraterone pharmacokinetics in healthy subjects and patients with metastatic castration-resistant prostate cancer;Chi;J. Clin. Pharmacol.,2015
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献